T cell-attracting CCL18 chemokine is a dominant rejection signal during limb transplantation
Thiago J Borges, Phammela Abarzua, Rodrigo B Gassen, Branislav Kollar, Mauricio Lima-Filho, Bruno T Aoyama, Diana Gluhova, Rachael A Clark, Sabina A Islam, Bohdan Pomahac, George F Murphy, Christine G Lian, Simon G Talbot, Leonardo V Riella, Thiago J Borges, Phammela Abarzua, Rodrigo B Gassen, Branislav Kollar, Mauricio Lima-Filho, Bruno T Aoyama, Diana Gluhova, Rachael A Clark, Sabina A Islam, Bohdan Pomahac, George F Murphy, Christine G Lian, Simon G Talbot, Leonardo V Riella
Abstract
Limb transplantation is a life-changing procedure for amputees. However, limb recipients have a 6-fold greater rejection rate than solid organ transplant recipients, related in part to greater immunogenicity of the skin. Here, we report a detailed immunological and molecular characterization of individuals who underwent bilateral limb transplantation at our institution. Circulating Th17 cells are increased in limb transplant recipients over time. Molecular characterization of 770 genes in skin biopsies reveals upregulation of T cell effector immune molecules and chemokines, particularly CCL18. Skin antigen-presenting cells primarily express the chemokine CCL18, which binds to the CCR8 receptor. CCL18 treatment recruits more allo-T cells to the skin xenograft in a humanized skin transplantation model, leading to signs of accelerated graft rejection. Blockade of CCR8 remarkedly decreases CCL18-induced allo-T cell infiltration. Our results suggest that targeting the CCL18:CCR8 pathway could be a promising immunosuppressive approach in transplantation.
Trial registration: ClinicalTrials.gov NCT01293214.
Keywords: CCL18; CCR8; chemokines; extremity; limb transplantation; rejection; upper extremity transplantation; vascular composite allograft.
Conflict of interest statement
The authors declare no competing interests.
© 2022 The Authors.
Figures
References
- Murray J.E. Organ transplantation (skin, kidney, heart) and the plastic surgeon. Plast. Reconstr. Surg. 1971;47:425–431.
- Kollar B., Pomahac B., Riella L.V. Novel immunological and clinical insights in vascularized composite allotransplantation. Curr. Opin. Organ Transpl. 2019;24:42–48.
- Hein R.E., Ruch D.S., Klifto C.S., Leversedge F.J., Mithani S.K., Pidgeon T.S., Richard M.J., Cendales L.C. Hand transplantation in the United States: a review of the organ procurement and transplantation network/united network for organ sharing database. Am. J. Transpl. 2019;20:1417–1423.
- Islam S.A., Ling M.F., Leung J., Shreffler W.G., Luster A.D. Identification of human CCR8 as a CCL18 receptor. J. Exp. Med. 2013;210:1889–1898.
- Günther C., Bello-Fernandez C., Kopp T., Kund J., Carballido-Perrig N., Hinteregger S., Fassl S., Schwärzler C., Lametschwandtner G., Stingl G., et al. CCL18 is expressed in atopic dermatitis and mediates skin homing of human memory T cells. J. Immunol. 2005;174:1723–1728.
- Park C.O., Lee H.J., Lee J.H., Wu W.H., Chang N.S., Hua L., Lee M.G., Lee K.H. Increased expression of CC chemokine ligand 18 in extrinsic atopic dermatitis patients. Exp. Dermatol. 2008;17:24–29.
- Vieyra-Garcia P., Crouch J.D., O’Malley J.T., Seger E.W., Yang C.H., Teague J.E., Vromans A.M., Gehad A., Win T.S., Yu Z., et al. Benign T cells drive clinical skin inflammation in cutaneous T cell lymphoma. JCI Insight. 2019;4:e124233.
- Weaver C.T., Elson C.O., Fouser L.A., Kolls J.K. The Th17 pathway and inflammatory diseases of the intestines, lungs, and skin. Annu. Rev. Pathol. Mech. Dis. 2013;8:477–512.
- Liu T., Li S., Ying S., Tang S., Ding Y., Li Y., Qiao J., Fang H. The IL-23/IL-17 pathway in inflammatory skin diseases: from bench to bedside. Front. Immunol. 2020;11:2971.
- Cendales L.C., Kanitakis J., Schneeberger S., Burns C., Ruiz P., Landin L., Remmelink M., Hewitt C.W., Landgren T., Lyons B., et al. The Banff 2007 working classification of skin-containing composite tissue allograft pathology. Am. J. Transplant. 2008;8:1396–1400.
- Tasigiorgos S., Kollar B., Turk M., Perry B., Alhefzi M., Kiwanuka H., Nizzi M.-C., Marty F.M., Chandraker A., Tullius S.G., et al. Five-Year follow-up after face transplantation. N. Engl. J. Med. 2019;380:2579–2581.
- Günther C., Zimmermann N., Berndt N., Grosser M., Stein A., Koch A., Meurer M. Up-regulation of the chemokine CCL18 by macrophages is a potential immunomodulatory pathway in cutaneous T-cell lymphoma. Am. J. Pathol. 2011;179:1434–1442.
- He H., Suryawanshi H., Morozov P., Gay-Mimbrera J., Del Duca E., Kim H.J., Kameyama N., Estrada Y., Der E., Krueger J.G., et al. Single-cell transcriptome analysis of human skin identifies novel fibroblast subpopulation and enrichment of immune subsets in atopic dermatitis. J. Allergy Clin. Immunol. 2020;145:1615–1628.
- Reynolds G., Vegh P., Fletcher J., Poyner E.F.M., Stephenson E., Goh I., Botting R.A., Huang N., Olabi B., Dubois A., et al. Developmental cell programs are co-opted in inflammatory skin disease. Science. 2021;371:eaba6500.
- Borges T.J., O’Malley J.T., Wo L., Murakami N., Smith B., Azzi J., Tripathi S., Lane J.D., Bueno E.M., Clark R.A., et al. Codominant role of interferon-γ– and interleukin-17–producing T cells during rejection in full facial transplant recipients. Am. J. Transpl. 2016;16:2158–2171.
- Krezdorn N., Lian C.G., Wells M., Wo L., Tasigiorgos S., Xu S., Borges T.J., Frierson R.M., Stanek E., Riella L.V., et al. Chronic rejection of human face allografts. Am. J. Transpl. 2019;19:1168–1177.
- Chung B.H., Kim K.W., Kim B.-M., Doh K.C., Cho M.-L., Yang C.W. Increase of Th17 cell phenotype in kidney transplant recipients with chronic allograft dysfunction. PLoS One. 2015;10:e0145258.
- Nova-Lamperti E., Romano M., Christakoudi S., Runglall M., McGregor R., Mobillo P., Kamra Y., Tsui T.-L., Norris S., John S., et al. Reduced TCR signaling contributes to impaired Th17 responses in tolerant kidney transplant recipients. Transplantation. 2018;102:e10–e17.
- Lian C.G., Bueno E.M., Granter S.R., Laga A.C., Saavedra A.P., Lin W.M., Susa J.S., Zhan Q., Chandraker A.K., Tullius S.G., et al. Biomarker evaluation of face transplant rejection: association of donor T cells with target cell injury. Mod. Pathol. 2014;27:788–799.
- Wu L., Chen X., Zhao J., Martin B., Zepp J.A., Ko J.S., Gu C., Cai G., Ouyang W., Sen G., et al. A novel IL-17 signaling pathway controlling keratinocyte proliferation and tumorigenesis via the TRAF4-ERK5 axis. J. Exp. Med. 2015;212:1571–1587.
- Clark R.A., Chong B., Mirchandani N., Brinster N.K., Yamanaka K.-I., Dowgiert R.K., Kupper T.S. The vast majority of CLA+ T cells are resident in normal skin. J. Immunol. 2006;176:4431–4439.
- Heath W.R., Carbone F.R. The skin-resident and migratory immune system in steady state and memory: innate lymphocytes, dendritic cells and T cells. Nat. Immunol. 2013;14:978–985.
- Etra J.W., Shores J.T., Sander I.B., Brandacher G., Lee W.P.A. Trauma-induced rejection in vascularized composite allotransplantation. Ann. Surg. 2020;271:e113–e114.
- Lopdrup R.G., Turk M., Win T.S., Marty F.M., Molway D., Tullius S.G., Pomahac B., Talbot S.G. Seasonal variability precipitating hand transplant rejection? Transplantation. 2017;101:e313.
- Tong P.L., Roediger B., Kolesnikoff N., Biro M., Tay S.S., Jain R., Shaw L.E., Grimbaldeston M.A., Weninger W. The skin immune atlas: three-dimensional analysis of cutaneous leukocyte subsets by multiphoton microscopy. J. Invest. Dermatol. 2015;135:84–93.
- Hautz T., Zelger B., Grahammer J., Krapf C., Amberger A., Brandacher G., Landin L., Pratschke J., Margreiter R., Schneeberger S. Molecular markers and targeted therapy of skin rejection in composite tissue allotransplantation. Am. J. Transpl. 2010;10:1200–1209.
- Dai H., Lan P., Zhao D., Abou-Daya K., Liu W., Chen W., Friday A.J., Williams A.L., Sun T., Chen J., et al. PIRs mediate innate myeloid cell memory to nonself MHC molecules. Science. 2020;368:1122–1127.
- Schaerli P., Ebert L., Willimann K., Blaser A., Roos R.S., Loetscher P., Moser B. A skin-selective homing mechanism for human immune surveillance T Cells. J. Exp. Med. 2004;199:1265–1275.
- Kim H.O., Cho S.I., Chung B.Y., Ahn H.K., Park C.W., Lee C.H. Expression of CCL1 and CCL18 in atopic dermatitis and psoriasis. Clin. Exp. Dermatol. 2012;37:521–526.
- Goebeler M., Trautmann A., Voss A., Bröcker E.B., Toksoy A., Gillitzer R. Differential and sequential expression of multiple chemokines during elicitation of allergic contact hypersensitivity. Am. J. Pathol. 2001;158:431–440.
- Schutyser E. Involvement of CC chemokine ligand 18 (CCL18) in normal and pathological processes. J. Leukoc. Biol. 2005;78:14–26.
- Colantonio L., Iellem A., Sinigaglia F., D’Ambrosio D. Skin-homing CLA+ T cells and regulatory CD25+ T cells represent major subsets of human peripheral blood memory T cells migrating in response to CCL1/I-309. Eur. J. Immunol. 2002;32:3506–3514.
- Kollar B., Shubin A., Borges T.J., Tasigiorgos S., Win T.S., Lian C.G., Dillon S.T., Gu X., Wyrobnik I., Murphy G.F., et al. Increased levels of circulating MMP3 correlate with severe rejection in face transplantation. Sci. Rep. 2018;8:14915.
- Kollar B., Uffing A., Borges T.J., Shubin A.V., Aoyama B.T., Dagot C., Haug V., Kauke M., Safi A.F., Talbot S.G., et al. MMP3 is a non-invasive biomarker of rejection in skin-bearing vascularized composite allotransplantation: a multicenter validation study. Front. Immunol. 2019;10:2771.
- Watarai Y., Koga S., Paolone D.R., Engeman T.M., Tannenbaum C., Hamilton T.A., Fairchild R.L. Intraallograft chemokine RNA and protein during rejection of MHC-matched/multiple minor histocompatibility-disparate skin grafts. J. Immunol. 2000;164:6027–6033.
- Hricik D.E., Nickerson P., Formica R.N., Poggio E.D., Rush D., Newell K.A., Goebel J., Gibson I.W., Fairchild R.L., Riggs M., et al. Multicenter validation of urinary CXCL9 as a risk-stratifying biomarker for kidney transplant injury. Am. J. Transpl. 2013;13:2634–2644.
- Ho J., Schaub S., Wiebe C., Gao A., Wehmeier C., Koller M.T., Hirsch H.H., Hopfer H., Nickerson P., Hirt-Minkowski P. Urinary CXCL10 chemokine is associated with alloimmune and virus compartment-specific renal allograft inflammation. Transplantation. 2018;102:521–529.
- Kaminski M.M., Alcantar M.A., Lape I.T., Greensmith R., Huske A.C., Valeri J.A., Marty F.M., Klämbt V., Azzi J., Akalin E., et al. A CRISPR-based assay for the detection of opportunistic infections post-transplantation and for the monitoring of transplant rejection. Nat. Biomed. Eng. 2020;4:601–609.
- Christofidou-Solomidou M., Longley B.J., Whitaker-Menezes D., Albelda S.M., Murphy G.F. Human skin/SCID mouse chimeras as an in vivo model for human cutaneous mast cell hyperplasia. J. Invest. Dermatol. 1997;109:102–107.
- Watanabe R., Gehad A., Yang C., Scott L.L., Teague J.E., Schlapbach C., Elco C.P., Huang V., Matos T.R., Kupper T.S., et al. Human skin is protected by four functionally and phenotypically discrete populations of resident and recirculating memory T cells. Sci. Transl. Med. 2015;7:279ra39.
- Racki W.J., Covassin L., Brehm M., Pino S., Ignotz R., Dunn R., Laning J., Graves S.K., Rossini A.A., Shultz L.D., et al. NOD-scid IL2rgamma(null) mouse model of human skin transplantation and allograft rejection. Transplantation. 2010;89:527–536.
- Borges T.J., Murakami N., Machado F.D., Murshid A., Lang B.J., Lopes R.L., Bellan L.M., Uehara M., Antunes K.H., Pérez-Saéz M.J., et al. March1-dependent modulation of donor MHC II on CD103+ dendritic cells mitigates alloimmunity. Nat. Commun. 2018;9:3482.
- Metsalu T., Vilo J. ClustVis: a web tool for visualizing clustering of multivariate data using principal component analysis and heatmap. Nucleic Acids Res. 2015;43:W566–W570.
- Mi H., Muruganujan A., Ebert D., Huang X., Thomas P.D. PANTHER version 14: more genomes, a new PANTHER GO-slim and improvements in enrichment analysis tools. Nucleic Acids Res. 2019;47:D419–D426.
Source: PubMed